Video

Studies on LENSAR show evidence that FLACS delivers better outcomes

Author(s):

Dr. Sri Ganesh, MBBS, MS, DNB, chairman and managing director of Nethradhama Hospital Pvt. Ltd, discusses his studies on LENSAR and shares his findings.

"The LENSAR platform is very stable, it’s user-friendly, quite accurate and I enjoy using it.”

Dr. Sri Ganesh, MBBS, MS, DNB, chairman and managing director of Nethradhama Hospital Pvt. Ltd, has been using the LENSAR phemto platform for the past several months, performing around 800 cases.

Dr. Ganesh discusses his multiple studies on the system, including comparing different astigmatic outcomes to the previous laser system he was using. In another study he compared femto-assisted cataract surgery versus just phaco, finding significant differences.

"The LENSAR platform is very stable, it’s user-friendly, quite accurate and I enjoy using it.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.